Global Cord Blood (NYSE:CO) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO) in a report published on Tuesday. The brokerage issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Stock Performance

Shares of NYSE:CO opened at $1.00 on Tuesday. Global Cord Blood has a 1-year low of $2.03 and a 1-year high of $5.50. The company’s fifty day moving average is $1.08 and its two-hundred day moving average is $1.35. The stock has a market capitalization of $121.55 million, a price-to-earnings ratio of 1.56 and a beta of 0.16.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.